Tesamorelin 5mg for Laboratory Research
Tesamorelin is a synthetic growth-hormone-releasing hormone (GHRH) analog studied for its role in GHRH-receptor signaling and lipid-metabolism research. This 5mg vial is supplied as a lyophilized powder at greater than 98% purity with a certificate of analysis and manufactured in the USA. It is sold strictly as a research chemical for in-vitro and laboratory use by qualified professionals. The 5mg size is an entry option suited to standard single-assay and short-series protocols.
Mechanism of Action
Tesamorelin is a stabilized analog of GHRH. In research models it binds the GHRH receptor on pituitary somatotroph cells and engages the secretory signaling axis studied in endocrine and metabolic research. Its structural modification improves stability relative to native GHRH under laboratory conditions.
Preclinical Research
GHRH analogs are widely used in endocrine and metabolic research to probe the somatotropic axis and downstream lipid and glucose handling in cell and animal models. Published literature examines receptor binding, secretory dynamics, and visceral-adipose models. These findings describe mechanisms in laboratory systems and do not establish outcomes in humans.
Research Applications
Tesamorelin is used as an investigational tool in GHRH-receptor and metabolic research. Laboratories studying related secretagogue pathways often run it alongside Ipamorelin, and it is also offered in pre-combined Tesamorelin and Ipamorelin blends. Reconstitution requires bacteriostatic water.
Available Sizes
Peptides Source supplies Tesamorelin across multiple vial sizes so laboratories can match material to protocol scale: 5mg (this page), 10mg, 20mg. Larger vials support extended or repeated in-vitro protocols.
Protocol & Handling
Reconstitute the lyophilized powder with bacteriostatic water to the concentration required by the study protocol. Store the sealed lyophilized vial at -20°C; once reconstituted, keep it refrigerated at 2 to 8°C and protect it from repeated freeze-thaw cycles. All handling should follow standard laboratory safety practice. These parameters describe in-vitro handling only.
Specifications
Compound: Tesamorelin (growth-hormone-releasing hormone analog) Quantity: 5mg per vial Purity: greater than 98% (third-party tested, COA available) Physical form: lyophilized powder Origin: manufactured in the USA Classification: research use only
Tesamorelin Frequently Asked Questions
What is Tesamorelin?
Tesamorelin is a synthetic, stabilized analog of growth-hormone-releasing hormone (GHRH) studied in laboratory research for GHRH-receptor signaling and metabolic pathways. It is supplied here for research use only.
How does Tesamorelin work in research models?
In cell and animal studies, Tesamorelin binds the GHRH receptor on pituitary somatotroph cells and engages the associated secretory signaling axis. These mechanisms are characterized in vitro and in animal models.
What purity is Peptides Source Tesamorelin?
Every batch is third-party tested to greater than 98% purity, with a certificate of analysis available. It is manufactured in the USA and supplied as a lyophilized powder.
How is Tesamorelin reconstituted and stored?
Reconstitute the lyophilized powder with bacteriostatic water to the desired research concentration. Store the sealed vial at -20°C and keep reconstituted material refrigerated at 2 to 8°C, avoiding repeated freeze-thaw cycles.
What sizes are available?
Tesamorelin is offered in 5mg, 10mg, and 20mg vials, and in pre-combined blends with Ipamorelin, so researchers can match material to protocol scale.
Is Tesamorelin for human use?
No. Tesamorelin is sold strictly as a research chemical for laboratory and in-vitro use by qualified professionals. It is not for human or animal consumption.
Research Use Only
All products supplied by Peptides Source are intended for laboratory research and in-vitro use only. They are not drugs, foods, or cosmetics, are not intended to diagnose, treat, cure, or prevent any disease or condition, and are not for human or animal consumption.